Amarin Corp Plcuk's ability to collect accounts receivable sequentially worsen to 1.49, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Amarin Plcuk's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 245 days, from 228 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 506 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 3137, from overall ranking in the first quarter 2026 at 3622.

What is Receivable Turnover Ratio?
What is Amarin Corp Plcuk Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AMRN Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	-30.71 %	3.68 %	8.95 %	8.48 %	-10.97 %
Y / Y Revenue Change	-41.63 %	7.41 %	-21.01 %	17.43 %	7.78 %
Receivable Turnover Ratio (TTM)	1.49	1.6	1.59	1.72	1.7
AMRN's Total Ranking	# 3137	# 3622	# 3205	# 3253	# 3317
Accounts Receivable average collection period days	246	229	230	212	215
Seq. Receivable Change	-24.48 %	-15.14 %	2.61 %	5.36 %	13 %
Seq. Revenue Change	-5.92 %	-8.3 %	-0.91 %	-31.72 %	73.12 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 167
Healthcare Sector	# 507
Overall Market	# 3137

Receivable Turnover Ratio Statistics
High	Average	Low
9.44	3.75	1.49
(Mar 31 2014)		(Jun 30 2026)

AMRN Company Profile • Back to AMRN Efficiency Comparisons • Compare AMRN Receivables Turnover Ratio to its Competitors

Financial Statements
Amarin Plcuk's Accounts Receivable	$ 93 Millions	Visit AMRN's Balance sheet
Amarin Plcuk's Sales TTM	$ 186 Millions	Visit AMRN's Income Statement
Sources of AMRN's Revenues		Visit AMRN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AMRN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AMRN's Growth Rates	AMRN's Roa	AMRN's Inventory Turnover Ratio	AMRN's Dividend Comparisons
AMRN's Profitability Ratios	AMRN's Roi	AMRN's Asset Turnover Ratio	AMRN's Dividend Growth
AMRN's Valuation Ratios	AMRN's Roe	AMRN's Financial Strength Ratios	AMRN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Johnson and Johnson	5.47	$ 97,929.000 Millions	$ 17,889.000 Millions
Merck and Co Inc	5.47	$ 66,569.000 Millions	$ 12,167.250 Millions
Quanterix Corporation	5.45	$ 152.716 Millions	$ 28.030 Millions
Xtant Medical Holdings Inc	5.44	$ 108.748 Millions	$ 19.979 Millions
Viskase Holdings inc	5.44	$ 177.054 Millions	$ 32.555 Millions
Ardelyx inc	5.44	$ 450.894 Millions	$ 82.913 Millions
Rigel Pharmaceuticals Inc	5.44	$ 276.785 Millions	$ 50.918 Millions
Alnylam Pharmaceuticals Inc	5.43	$ 4,804.182 Millions	$ 884.758 Millions
Sintx Technologies Inc	5.37	$ 1.330 Millions	$ 0.248 Millions
Cytokinetics Incorporated	5.33	$ 67.670 Millions	$ 12.708 Millions
Progyny Inc	5.28	$ 1,311.298 Millions	$ 248.469 Millions
Strata Critical Medical Inc	5.27	$ 211.642 Millions	$ 40.126 Millions
Karyopharm Therapeutics Inc	5.27	$ 146.621 Millions	$ 27.821 Millions
Seer Inc	5.24	$ 14.377 Millions	$ 2.746 Millions
Enovis Corp	5.21	$ 2,294.938 Millions	$ 440.151 Millions
The Cooper Companies Inc	5.20	$ 4,236.600 Millions	$ 814.025 Millions
Cryoport inc	5.19	$ 186.452 Millions	$ 35.933 Millions
Elutia Inc	5.16	$ 11.353 Millions	$ 2.198 Millions
Opus Genetics Inc	5.13	$ 9.856 Millions	$ 1.921 Millions
Carlsmed Inc	5.13	$ 62.457 Millions	$ 12.175 Millions
West Pharmaceutical Services Inc	5.12	$ 3,326.900 Millions	$ 649.250 Millions
Elanco Animal Health Incorporated	5.11	$ 5,020.000 Millions	$ 982.000 Millions
Repligen Corp	5.09	$ 785.101 Millions	$ 154.205 Millions
Indivior Pharmaceuticals Inc	5.05	$ 1,333.000 Millions	$ 264.000 Millions
Inspiremd Inc	5.05	$ 10.502 Millions	$ 2.082 Millions
Sarepta Therapeutics Inc	5.04	$ 1,974.344 Millions	$ 391.403 Millions
Pacific Biosciences Of California Inc	5.04	$ 159.315 Millions	$ 31.630 Millions
Amphastar Pharmaceuticals Inc	5.01	$ 730.019 Millions	$ 145.768 Millions
Invivyd Inc	5.01	$ 58.365 Millions	$ 11.660 Millions
Zimmer Biomet Holdings Inc	5.00	$ 8,508.800 Millions	$ 1,700.200 Millions

Date modified: 2026-10-15T05:23:37+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.